Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Cameroon (vol 12, pg S50, 2007)d

被引：0
|
作者：
Nkengafac, A. D. [1 ]
Tina, S. [1 ]
Sua, F. [1 ]
Mason, T. [1 ]
Auyuketta, N. [1 ]
Oben, S. [1 ]
机构：
[1] Inst Adv Med Sci, Buea, Cameroon
来源：
ANTIVIRAL THERAPY | 2008年 / 13卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：845 / 845
页数：1
相关论文
共 50 条
  • [41] HIV-1 drug resistance-associated mutations in relation to viral load among HIV/AIDS patients at Dr. M. Djamil-Hospital Padang
    Nadia, Rizka
    Elvira, Dwitya
    Raveinal
    UNIVERSA MEDICINA, 2024, 43 (01) : 38 - 43
  • [42] Prevalence of HIV-1 drug resistance-associated mutations in a large cohort of antiretroviral therapy (ART) naive HIV-infected individuals in the United States from 2000-2004
    Ross, L. L.
    Florance, A.
    Wine, B.
    Craig, C.
    Vavro, C.
    McClernon, D.
    Tisdale, M.
    Balu, R.
    Lancaster, T.
    Shaefer, M.
    Lanier, E. R.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S120 - S120
  • [43] Prevalence of Drug-Resistant HIV-1 in Rural Areas of Hubei Province in the People's Republic of China (vol 50, pg 1, 2009)
    Luo
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (03) : 343 - 343
  • [44] HIV-1 molecular epidemiology and prevalence of drug resistance in treatment-naive and HAART-treated patients between 2003 and 2009 in Rwanda
    Karasi, J-C
    Musonera, F.
    Servais, J. Y.
    Lambert, C.
    Struck, D.
    Limberger, M-A
    Makombe, N.
    Iranyunviye, K.
    Habimana, M.
    Omes-Karasi, C.
    Devaux, C.
    Schmit, J. C.
    Arendt, V.
    ANTIVIRAL THERAPY, 2010, 15 : A143 - A143
  • [45] Prevalence of HIV-1 Subtypes and Drug Resistance-Associated Mutations in HIV-1-Positive Treatment-Naive Pregnant Women in Pointe Noire, Republic of the Congo (Kento-Mwana Project)
    Bruzzone, Bianca
    Saladini, Francesco
    Sticchi, Laura
    Mboungou, Franc A. Mayinda
    Barresi, Renata
    Caligiuri, Patrizia
    Calzi, Anna
    Zazzi, Maurizio
    Icardi, Giancarlo
    Viscoli, Claudio
    Bisio, Francesca
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (08) : 837 - 840
  • [46] Profile of the HIV Epidemic in Cape Verde: Molecular Epidemiology and Drug Resistance Mutations among HIV-1 and HIV-2 Infected Patients from Distinct Islands of the Archipelago
    de Pina-Araujo, Isabel Ines M.
    Guimaraes, Monick L.
    Bello, Gonzalo
    Vicente, Ana Carolina P.
    Morgado, Mariza G.
    PLOS ONE, 2014, 9 (04):
  • [47] Prevalence of Antiretroviral Drug Resistance Mutations and HIV-1 Subtypes among Newly-diagnosed Drug-naive Persons Visiting A Voluntary Testing and Counselling Centre in Northeastern South Africa
    Nwobegahay, Julius M.
    Bessong, Pascal O.
    Masebe, Tracy M.
    Mavhandu, Lufuno G.
    Iweriebor, Benson C.
    Selabe, Gloria
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2011, 29 (04) : 303 - 309
  • [48] Prevalence and factors associated with HIV-1 drug resistance mutations in treatment-experienced patients in Nairobi, Kenya A cross-sectional study
    Scriven, Yvonne A.
    Mulinge, Martin M.
    Saleri, Norah
    Luvai, Elizabeth A.
    Nyachieo, Atunga
    Maina, Esther N.
    Mwau, Matilu
    MEDICINE, 2021, 100 (40) : E27460
  • [49] Changes in the regional prevalence of HIV-1 drug resistance-associated mutations and in the prevalence of non-clade B sub types in antiretroviral therapy-naive HIV-infected patients in the United States from 2000-2006
    Ross, L. L.
    Williams, V.
    Wine, B.
    Vavro, C.
    Craig, C.
    McClemon, D.
    Tisdale, M.
    Balu, R.
    Lancaster, T.
    Horton, J.
    Pappa, K.
    Lanier, E. R.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S54 - S54
  • [50] Changes in the regional prevalence of HIV-1 drug resistance-associated mutations and in the prevalence of non-clade B sub types in antiretroviral therapy-naive HIV-infected patients in the United States from 2000-2006
    Ross, L. L.
    Williams, V.
    Wine, B.
    Vavro, C.
    Craig, C.
    McClernon, D.
    Tisdale, M.
    Balu, R.
    Lancaster, T.
    Horton, J.
    Pappa, K.
    Lanier, E. R.
    ANTIVIRAL THERAPY, 2007, 12 : S54 - S54
12345